Matthew M. Gosling
2014
In 2014, Matthew M. Gosling earned a total compensation of $1.4M as Senior Vice President and General Counsel at DepoMed, a 51% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $188,407 |
|---|---|
| Option Awards | $392,122 |
| Salary | $396,596 |
| Stock Awards | $444,150 |
| Other | $7,586 |
| Total | $1,428,861 |
Gosling received $444.2K in stock awards, accounting for 31% of the total pay in 2014.
Gosling also received $188.4K in non-equity incentive plan, $392.1K in option awards, $396.6K in salary and $7.6K in other compensation.
Rankings
In 2014, Matthew M. Gosling's compensation ranked 5,988th out of 13,032 executives tracked by ExecPay. In other words, Gosling earned more than 54.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,988 out of 13,032 | 54th |
Division Manufacturing | 2,166 out of 4,966 | 56th |
Major group Chemicals And Allied Products | 719 out of 1,686 | 57th |
Industry group Drugs | 559 out of 1,365 | 59th |
Industry Pharmaceutical Preparations | 432 out of 1,043 | 59th |
Source: SEC filing on July 14, 2017.
Gosling's colleagues
We found five more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2014.
2014
James Schoeneck
DepoMed
Chief Executive Officer
2014
Thadd Vargas
DepoMed
Senior Vice President, Business Development
2014
August Moretti
DepoMed
Chief Financial Officer
2014
R Shively
DepoMed
Former Senior Vice President and Chief Commercial Officer
2014
Srinivas Rao
DepoMed